However, in control BMD-MSCs (Supplementary Figure S6C), the presumptive progenitor cells to EWS [36], the combination was not effective in inhibiting cell growth, indicating enhanced sensitivity of these drugs to more rapidly proliferating cancer cells and a possible therapeutic window for this drug combination. The gene discussed is EWSR1; the disease is cancer.